A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LMP1 / latent membrane protein 1

[Related PubMed/MEDLINE]
Total Number of Papers: 1088
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LMP1  (>> Co-occurring Abbreviation)
Long Form:   latent membrane protein 1
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation. EBV, IKK2, JNK, TAK1, Tpl2
2020 Capn4 is induced by and required for Epstein-Barr virus latent membrane protein 1 promotion of nasopharyngeal carcinoma metastasis through ERK/AP-1 signaling. CTAR, NPC
2020 Carboxyl terminal activating region 3 of latent membrane protein 1 encoded by the Epstein‑Barr virus regulates cell proliferation and protein expression in NP69 cells. CTAR3, JAK3
2020 CD47 Overexpression Is Associated with Epstein-Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma. DFS, EBV, NPC, siRNA
2020 Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. Drp1, EBV, NPC
2020 Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. Drp1, EBV, NPC
2020 Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival. DUSPs, EBV, ERK, LCLs, MAPKs
2020 EBV-LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer. A3B, A3s, EBV, NPC
2020 Epstein-Barr Virus LMP1 Promotes Syntenin-1- and Hrs-Induced Extracellular Vesicle Formation for Its Own Secretion To Increase Cell Proliferation and Migration. BioID, CHMPs, EBV, EVs
10  2020 Epstein-Barr virus-encoded latent membrane protein 1 promotes extracellular vesicle secretion through syndecan-2 and synaptotagmin-like-4 in nasopharyngeal carcinoma cells. EBV, EVs, NF, NPC, SDC2, SYTL4
11  2020 Evaluation of the effect of 5-aminolevulinic acid hexyl ester (H-ALA) PDT on EBV LMP1 protein expression in human nasopharyngeal cells. EBV, NPC, PDT
12  2020 Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling. CAFs, EBV, EVs, NFs, NPC, RWE
13  2020 Hodgkin lymphoma: a review of pathological features and recent advances in pathogenesis. EBV, ER, HL, RS
14  2020 LMP1 promotes nasopharyngeal carcinoma metastasis through NTRK2-mediated anoikis resistance. EBV, EMT, NPC
15  2020 LMP1 Up-regulates Calreticulin to Induce Epithelial-mesenchymal Transition via TGF-beta/Smad3/NRP1 Pathway in Nasopharyngeal Carcinoma Cells. CRT, EMT, NPC, NRP-1
16  2020 LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders. CIK, EBV-CTLs, PTLD
17  2020 Oligomerization analysis as a tool to elucidate the mechanism of EBV latent membrane protein 1 inhibition by pentamidine. EBV
18  2020 Overexpression of Semaphorin 3A is a Marker Associated with Poor Prognosis in Patients with Nasopharyngeal Carcinoma. NPC, Sema3A
19  2020 Targeting EZH2 depletes LMP1-induced activated regulatory T cells enhancing antitumor immunity in nasopharyngeal carcinoma. aTregs, EBV, EZH2, NPC, TAA
20  2020 The Anti-Apoptotic Role of EBV-LMP1 in Lymphoma Cells. Bcl-2, EBV, MDM2
21  2020 Toll-like receptor 3 (TLR3) functions as a pivotal target in latent membrane protein 1 (LMP1)-mediated nasopharyngeal carcinoma cell proliferation. EBV, KD, NPC, TLR3
22  2020 Translational genomics of nasopharyngeal cancer. EBV, NPC
23  2020 Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis. 2-HG, alpha-KG, ChIP, EBV, HNSCC, IDH2, PCR, VCA-IgA
24  2019 ATR activated by EB virus facilitates chemotherapy resistance to cisplatin or 5-fluorouracil in human nasopharyngeal carcinoma. 5-FU, ATM, Chk1, EBV, NPC, NPI
25  2019 B1.12: a novel peptide interacting with the extracellular loop of the EBV oncoprotein LMP1. EBV
26  2019 Cancer-Associated Fibroblasts in Undifferentiated Nasopharyngeal Carcinoma: A Putative Role for the EBV-Encoded Oncoprotein, LMP1. CAFs, EBV, NPC
27  2019 Construction of Epstein-Bar virus cocktail peptide fused with Fcgamma of IgG: as a potential delivery system for vaccine development. EBV, GP
28  2019 CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth. EBV, eIF4E, NPC, RT-qPCR, sgRNA
29  2019 Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma. CDK1, EBV, NNKTL
30  2019 EBV LMP1 in Gingival Epithelium Potentially Contributes to Human Chronic Periodontitis via Inducible IL8 Production. CATR, EBV, ELISA, IBalpha, IL-8, NF-B
31  2019 EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2. 3'UTR, ABCs, BHRF1, COO, DLBCLs, GCBs, miR, PD-L1
32  2019 Efficient Epstein-Barr Virus Progeny Production Mediated by Cancer-Derived LMP1 and Virally-Encoded microRNAs. BAC, EBV, LMP1B95-8, miRNA, NPC
33  2019 Epstein-Barr virus infection in gliomas. EBER, EBV, GBM, PCR
34  2019 Epstein-Barr virus latent membrane protein 1 (LMP1) regulates the aldehyde dehydrogenase (ALDH) positive cell population in nasopharyngeal carcinoma cell lines. ALDH, ALDH1, CK19, CSCs, EBV, IHC, NPC
35  2019 Epstein-Barr Virus Latent Membrane Protein 1 Regulates Host B Cell MicroRNA-155 and Its Target FOXO3a via PI3K p110alpha Activation. EBV, miRs, PTLD, SMI
36  2019 Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells. ---
37  2019 Epstein-Barr virus-encoded LMP1 induces ectopic CD137 expression on Hodgkin and Reed-Sternberg cells via the PI3K-AKT-mTOR pathway. APC, EBV, HL, HRS
38  2019 Essential role of inverted repeat in Epstein-Barr virus IR-1 in B cell transformation; geographical variation of the viral genome. EBV, invR
39  2019 Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma. CyPA, EBV, ELISA, NPC
40  2019 F factor plasmid-mediated Epstein-Barr virus genome introduction establishes an EBV positive NPC cell model. EBERs, EBNA1, EBV, LMP2A, NPC, TEM
41  2019 Fibronectin promotes nasopharyngeal cancer cell motility and proliferation. EBV, HIF-1alpha, NPC, TGF-beta1
42  2019 Follicular dendritic cells display microvesicle-associated LMP1 in reactive germinal centers of EBV+ classic Hodgkin lymphoma. cHL, EBER, EBV, FDCs, GC, MC, NS
43  2019 Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type. CTL, EBNA1, EBV, NK, NKTCL
44  2019 Inhibition of UCH-L1 Deubiquitinating Activity with Two Forms of LDN-57444 Has Anti-Invasive Effects in Metastatic Carcinoma Cells. DUB, EBV, ECV, LDN-POx, NP, OSCC, UCH-L1
45  2019 Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-kappaB axis during nasopharyngeal carcinoma development. ChIP, EBV, NPC
46  2019 LMP1 expression in bone marrow trephines of patients with multiple myeloma confers a survival advantage. ALDH1, BM, EBV, MM
47  2019 LMP1 gene detection using a capped gold nanowire array surface plasmon resonance sensor in a microfluidic chip. SPR
48  2019 Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma. EBV, OL, OSCC
49  2019 p53, latent membrane protein 1, bcl-2, and prognosis in nasopharyngeal carcinoma: a meta-analysis. NPC, OR, RD
50  2019 Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC-subtype diffuse large B-cell lymphoma. ABC, DLBCL, EBV, GC, PI3K, S1P
51  2019 Targeting Exosomal EBV-LMP1 Transfer and miR-203 Expression via the NF-kappaB Pathway: The Therapeutic Role of Aspirin in NPC. EBV, EMT, exo-LMP1, exo-miR203, miR-203, NF-kappaB, NPC
52  2019 Targeting trimeric transmembrane domain 5 of oncogenic latent membrane protein 1 using a computationally designed peptide. EBV
53  2019 The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease. EBV
54  2019 The JAK inhibitor antcin H exhibits direct anticancer activity while enhancing chemotherapy against LMP1-expressed lymphoma. EBV, MTX, ZAA
55  2019 Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency. EBV
56  2019 [Establishment of human B lymphocyte strain overexpressing Epstein-Barr virus latent membrane protein 1 (LMP1)]. ---
57  2018 (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1. EBV, EGCG
58  2018 A novel Epstein-Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy. EBV, TCR
59  2018 Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma. EBV, FASN, mTOR, NPC, siRNA, SREBP1
60  2018 Blockage of store-operated Ca2+ entry antagonizes Epstein-Barr virus-promoted angiogenesis by inhibiting Ca2+ signaling-regulated VEGF production in nasopharyngeal carcinoma. 2-APB, EBV, EGF, ELISA, HUVECs, NPC, VEGF
61  2018 Bystander inhibition of humoral immune responses by Epstein-Barr virus LMP1. AID, ASCs, EBV, GC, IDO1, WT
62  2018 C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes. EBV, NPC, UCH-L1
63  2018 Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination. CMV, EBV, HSV, RHIM, RIPK1
64  2018 Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis. MS
65  2018 Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A. DUB, EBV, IPA
66  2018 IL-2Ralpha up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma. IL-2R alpha, NKTCL
67  2018 LIMD1 is induced by and required for LMP1 signaling, and protects EBV-transformed cells from DNA damage-induced cell death. DDR, EBV, LIMD1
68  2018 Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups. CTAR, EBV, NPC
69  2018 Modulation of the tumor microenvironment by Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma. NPC
70  2018 Molecular Grading of Oral Squamous Cell Carcinomas Infected with EBV EBNA-1, EBV, OSCCs, SCC
71  2018 Molecular signature of Epstein-Barr virus infection in MS brain lesions. EBER-1, EBV
72  2018 New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma. EBV, NPC
73  2018 Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma. CR, EBV, ENKTCL
74  2018 Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1. EBV, HIF-1alpha, PARP1, PARylation
75  2018 Role of microRNAs and Exosomes in Helicobacter pylori and Epstein-Barr Virus Associated Gastric Cancers. CagA, EBV, H. pylori, miRNAs
76  2018 Tetraspanin CD63 Bridges Autophagic and Endosomal Processes To Regulate Exosomal Secretion and Intracellular Signaling of Epstein-Barr Virus LMP1 EBV, EV, mTOR
77  2018 The EBV-Encoded Oncoprotein, LMP1, Induces an Epithelial-to-Mesenchymal Transition (EMT) via Its CTAR1 Domain through Integrin-Mediated ERK-MAPK Signalling. EBV, EMT, ERK-MAPK, FAK, MDCK
78  2018 Transmembrane Domains Mediate Intra- and Extracellular Trafficking of Epstein-Barr Virus Latent Membrane Protein 1. EVs
79  2017 A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway. ADCC, CDC, EBV, IHC, NK, WB
80  2017 Association of Epstein - Barr virus and breast cancer in Eritrea. EBER, EBV, ISH, LMP2a, PCR
81  2017 CD63 Regulates Epstein-Barr Virus LMP1 Exosomal Packaging, Enhancement of Vesicle Production, and Noncanonical NF-kappaB Signaling. EBV, EVs, MAPK/ERK, MVBs
82  2017 Characterization of a Suppressive Cis-acting Element in the Epstein-Barr Virus LMP1 Promoter. EBV
83  2017 Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells. EBV, IE, NPC, OHL, TPA
84  2017 Disruption of direct 3D telomere-TRF2 interaction through two molecularly disparate mechanisms is a hallmark of primary Hodgkin and Reed-Sternberg cells. cHL, EBV, RS, TRF2
85  2017 EBV-Directed T Cell Therapeutics for EBV-Associated Lymphomas. EBV, GMP
86  2017 EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53. cHL, DLBCL, EBER, EBV, FISH, NGS, PTLDs, VOUS
87  2017 Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells. EBV
88  2017 Enhanced aerobic glycolysis of nasopharyngeal carcinoma cells by Epstein-Barr virus latent membrane protein 1. EBV, LDH, NPC, PDK1, PKM2
89  2017 Epstein Barr virus Latent Membrane Protein-1 enhances dendritic cell therapy lymph node migration, activation, and IL-12 secretion. Ad5, DC
90  2017 Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines. EBV, LCLs
91  2017 Epstein-Barr virus infection and breast invasive ductal carcinoma in Egyptian women: A single center experience. EBNA-1, EBV, IDC, IHC
92  2017 Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma. EBV, HL, IL, MIP
93  2017 Epstein-Barr Virus LMP1-Mediated Oncogenicity. EBV
94  2017 Epstein-Barr virus-encoded latent membrane protein 1 induces epithelial to mesenchymal transition by inducing V-set Ig domain containing 4 (VSIG4) expression via NF-kB in renal tubular epithelial HK-2cells. EBV, EMT, VSIG4
95  2017 Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-kappaB Signaling Pathways. CTAR2, EBV, GLUT1, NPC, NPE
96  2017 Epstein-Barr virus-positive follicular lymphoma. EBV
97  2017 Exome and genome sequencing of nasopharynx cancer identifies NF-kappaB pathway activating mutations. EBV, NPC, WES, WGS
98  2017 Exposure to the Epstein-Barr Viral Antigen Latent Membrane Protein 1 Induces Myelin-Reactive Antibodies In Vivo. CNS, EBV, FDCs, MBP, MS
99  2017 Expression of interferon regulatory factor 7 correlates with the expression of Epstein-Barr Virus latent membrane protein 1 and cervical lymph node metastasis in nasopharyngeal cancer. EBV, IRF7, NPC
100  2017 Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential. EBNA3A, EBV, LCLs